BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15332577)

  • 1. [Molecular, genetic, and cellular aspects of the heart and vessel remodeling in hypertension (review)].
    Shliakhto EV; Konradi AO; Moiseeva OM
    Ter Arkh; 2004; 76(6):51-8. PubMed ID: 15332577
    [No Abstract]   [Full Text] [Related]  

  • 2. [Left ventricular hypertrophy. Pathogenetic issues].
    Riazanov AS; Smirnova MD; Iurenev AP
    Ter Arkh; 2000; 72(2):72-7. PubMed ID: 10717936
    [No Abstract]   [Full Text] [Related]  

  • 3. The muscle-collagen ratio in left ventricular hypertrophy and aorta remodelling in hypertension.
    Rossi MA
    Acta Physiol (Oxf); 2008 Sep; 194(1):1-2. PubMed ID: 18694419
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of daidzein on left ventricular remodeling in rats with hypertrophic myocardium induced by pressure overload].
    Zhou L; Zhou Q; Xiong XQ; Liu JX; He W
    Zhongguo Zhong Yao Za Zhi; 2007 Jul; 32(14):1449-52. PubMed ID: 17966363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lonely failing heart: a case for ECM genes.
    Weber KT
    Cardiovasc Res; 1995 Dec; 30(6):835. PubMed ID: 8746195
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
    Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial gene expression associated with genetic cardiac hypertrophy in the absence of hypertension.
    Dwyer JP; Ritchie ME; Smyth GK; Harrap SB; Delbridge L; Domenighetti AA; Di Nicolantonio R
    Hypertens Res; 2008 May; 31(5):941-55. PubMed ID: 18712050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of left ventricular mass in hypertensive heart disease: a complex interplay between volume, pressure, systolic function and genes.
    Perlini S
    J Hypertens; 2007 Jul; 25(7):1341-2. PubMed ID: 17563551
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the deficiency of the long isoform of cellular FLICE-inhibitory protein involved in myocardial remodeling?
    Díez J; González A; Ravassa S
    Hypertension; 2010 Dec; 56(6):1045-6. PubMed ID: 20975034
    [No Abstract]   [Full Text] [Related]  

  • 11. Iptakalim: a new or just another KCO?
    Costa AD
    Cardiovasc Res; 2009 Aug; 83(3):417-8. PubMed ID: 19515796
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy.
    Gallego-Delgado J; Lazaro A; Osende JI; Barderas MG; Duran MC; Vivanco F; Egido J
    J Proteome Res; 2006 Feb; 5(2):404-13. PubMed ID: 16457607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy: beyond the image and defining the human cardiac phenotype in hypertension.
    Jennings GL; McMullen JR
    J Hypertens; 2007 May; 25(5):941-7. PubMed ID: 17414655
    [No Abstract]   [Full Text] [Related]  

  • 14. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
    Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
    Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-aldosterone, adrenergic, and metalloproteinase systems.
    Bauters C; Lamblin N; Ennezat PV; Mycinski C; Tricot O; Nugue O; Segrestin B; Hannebicque G; Agraou B; Polge AS; de Groote P; Helbecque N; Amouyel P;
    Am Heart J; 2007 Apr; 153(4):641-8. PubMed ID: 17383306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference targeting the ACE gene reduced blood pressure and improved myocardial remodelling in SHRs.
    He J; Bian Y; Gao F; Li M; Qiu L; Wu W; Zhou H; Liu G; Xiao C
    Clin Sci (Lond); 2009 Feb; 116(3):249-55. PubMed ID: 18605985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs Regulating Renin-Angiotensin-Aldosterone System, Sympathetic Nervous System and Left Ventricular Hypertrophy in Systemic Arterial Hypertension.
    Improta-Caria AC; Aras MG; Nascimento L; De Sousa RAL; Aras-Júnior R; Souza BSF
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.
    Tsuneyoshi H; Nishina T; Nomoto T; Kanemitsu H; Kawakami R; Unimonh O; Nishimura K; Komeda M
    Circulation; 2004 Sep; 110(11 Suppl 1):II174-9. PubMed ID: 15364859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix remodeling in hypertensive heart disease.
    Shirwany A; Weber KT
    J Am Coll Cardiol; 2006 Jul; 48(1):97-8. PubMed ID: 16814654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.